Y-Biologics Inc. (338840)
Market Open
11 Aug, 06:30
KRX SM KRX SM Primary ₩
11,280. 00
-90
-0.7916%
₩
480.62B Market Cap
- P/E Ratio
- Div Yield
70,239 Volume
- Eps
₩ 11,370
Previous Close Want to track 338840 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
338840 trading today lower at ₩11,280, a decrease of -0.7916% from yesterday's close, completing a monthly decrease of -5.4484% or -₩650. Over the past 12 months, 338840 stock lost -51.1688%.
338840 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
Y-Biologics Inc. (338840) FAQ
What is the stock price today?
The current price is ₩11,280.00.
On which exchange is it traded?
Y-Biologics Inc. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 338840.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 480.62B.
Has Y-Biologics Inc. ever had a stock split?
No, there has never been a stock split.
Y-Biologics Inc. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Young Woo Park CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Y-Biologics Inc. is a biotechnology firm primarily engaged in developing antibody-based drugs and therapeutic solutions. The company focuses on innovative research and development to advance treatments for various diseases, including cancer and immune-related disorders. By leveraging cutting-edge technology in monoclonal antibody production, Y-Biologics aims to provide more effective and safer therapeutic options. The company's operations significantly impact the healthcare and pharmaceutical sectors, contributing to the evolving landscape of targeted medicine. Moreover, Y-Biologics Inc. holds a strategic position in the biotechnological market due to its robust pipeline of proprietary drug candidates and collaborative efforts with other industry players. Through its commitment to enhancing patient outcomes, Y-Biologics stands out as a notable entity within the life sciences arena, fostering healthcare advancements and exploring new frontiers in drug discovery and development.
Contact Information
Address: #715-B, 17 Techno 4-ro
Phone: 82 4 2867 9971
Website: https://www.ybiologics.com
